These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18729628)

  • 21. Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.
    Luster BR; Cogan ES; Schmidt KT; Pati D; Pina MM; Dange K; McElligott ZA
    Addict Biol; 2020 May; 25(3):e12748. PubMed ID: 30963693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of actin rearrangements within the amygdala and the dorsal hippocampus in aversive memories of drug withdrawal in acute morphine-dependent rats.
    Hou YY; Lu B; Li M; Liu Y; Chen J; Chi ZQ; Liu JG
    J Neurosci; 2009 Sep; 29(39):12244-54. PubMed ID: 19793983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lesions of the lateral parabrachial nucleus block the aversive motivational effects of both morphine and morphine withdrawal but spare morphine's discriminative properties.
    Nader K; Bechara A; van der Kooy D
    Behav Neurosci; 1996 Dec; 110(6):1496-502. PubMed ID: 8986351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning.
    Smith JW; Fetsko LA; Xu R; Wang Y
    Neuroscience; 2002; 113(4):755-65. PubMed ID: 12182883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
    Manwell LA; Satvat E; Lang ST; Allen CP; Leri F; Parker LA
    Pharmacol Biochem Behav; 2009 Nov; 94(1):154-62. PubMed ID: 19698735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic analysis of male rat nucleus accumbens, dorsal hippocampus and amygdala on conditioned place aversion induced by morphine withdrawal.
    Guo LB; Yu C; Ling QL; Fu Y; Wang YJ; Liu JG
    Behav Brain Res; 2019 Oct; 372():112008. PubMed ID: 31173798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
    Rothwell PE; Thomas MJ; Gewirtz JC
    Neuropsychopharmacology; 2009 Sep; 34(10):2285-95. PubMed ID: 19494807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precipitated morphine withdrawal induces a conditioned aversion in the preweaning rat.
    Barr GA; Goodwin GA
    Pharmacol Biochem Behav; 1997 Aug; 57(4):779-83. PubMed ID: 9259006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DREAM ablation selectively alters THC place aversion and analgesia but leaves intact the motivational and analgesic effects of morphine.
    Cheng HY; Laviolette SR; van der Kooy D; Penninger JM
    Eur J Neurosci; 2004 Jun; 19(11):3033-41. PubMed ID: 15182311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
    Hodgson SR; Hofford RS; Norris CJ; Eitan S
    Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking microglial pannexin-1 channels alleviates morphine withdrawal in rodents.
    Burma NE; Bonin RP; Leduc-Pessah H; Baimel C; Cairncross ZF; Mousseau M; Shankara JV; Stemkowski PL; Baimoukhametova D; Bains JS; Antle MC; Zamponi GW; Cahill CM; Borgland SL; De Koninck Y; Trang T
    Nat Med; 2017 Mar; 23(3):355-360. PubMed ID: 28134928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditioned aversive memory associated with morphine withdrawal increases brain-derived neurotrophic factor in dentate gyrus and basolateral amygdala.
    Martínez-Laorden E; Navarro-Zaragoza J; Milanés MV; Laorden ML; Almela P
    Addict Biol; 2020 Jul; 25(4):e12792. PubMed ID: 31282111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal.
    Frenois F; Cador M; Caillé S; Stinus L; Le Moine C
    Eur J Neurosci; 2002 Oct; 16(7):1377-89. PubMed ID: 12405997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ameliorating effect of histamine on impairment of cued fear extinction induced by morphine withdrawal in histidine decarboxylase gene knockout mice.
    Gong YX; Shou WT; Feng B; Zhang WP; Wang HJ; Ohtsu H; Chen Z
    Acta Pharmacol Sin; 2010 Nov; 31(11):1431-7. PubMed ID: 21052083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.
    Valverde O; Tzavara E; Hanoune J; Roques BP; Maldonado R
    Eur J Neurosci; 1996 Dec; 8(12):2671-8. PubMed ID: 8996817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
    Maldonado C; Cauli O; Rodríguez-Arias M; Aguilar MA; Miñarro J
    Behav Brain Res; 2003 Sep; 144(1-2):25-35. PubMed ID: 12946592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Rasmussen K; Kendrick WT; Kogan JH; Aghajanian GK
    Neuropsychopharmacology; 1996 Nov; 15(5):497-505. PubMed ID: 8914123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactivity and plasticity in the amygdala nuclei during opiate withdrawal conditioning: differential expression of c-fos and arc immediate early genes.
    Lucas M; Frenois F; Vouillac C; Stinus L; Cador M; Le Moine C
    Neuroscience; 2008 Jun; 154(3):1021-33. PubMed ID: 18501523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.